three hundred thirty-two eligible patients with advanced ( ann arbor stage iii or iv ) non-hodgkin 's lymphoma of aggressive histologic subtype ( rappaport classification diffuse histiocytic [ dh ] , diffuse poorly differentiated lymphocytic [ dpdl ] , diffuse mixed [ dm ] , or diffuse undifferentiated [ du ] ) were randomly assigned to receive induction chemotherapy with one of three intensive regimens in a clinical trial conducted by the eastern cooperative oncology group ( ecog ) between 1978 and 1983 .
C1332225
non-hodgkin 's lymphoma
C0024264
lymphocytic